Publications by authors named "T Witthoeft"

Claim this Profile
P
Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response.
A Craxi, S Koutsounas, P Ogurtsov, L Chemello, M Maticic, T Witthoeft

J Viral Hepat· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the likelihood of sustained virological response in chronic hepatitis C therapy.
S Mauss, D Hueppe, C John, J Goelz, R Heyne, T Witthoeft

J Viral Hepat· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: the PRACTICE study.
T Witthoeft, D Hueppe, C John, J Goelz, R Heyne

J Viral Hepat· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent i.v.-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: an open-label pilot study.
Th Witthoeft, M Fuchs, D Ludwig

World J Gastroenterol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.
Klaus R Herrlinger, Thomas Witthoeft, Andreas Raedler, Bernd Bokemeyer, Thomas Krummenerl

Am J Gastroenterol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis